ro 31-8220 has been researched along with Insulin Resistance in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose-response curves for glucose uptake were fitted to a quadratic function to derive C(I-150) values (concentration of insulin required to increase glucose uptake by 50%)." | 1.31 | Effects of tumour necrosis factor-alpha and inhibition of protein kinase C on glucose uptake in L6 myoblasts. ( Donnelly, R; Gray, S; Idris, I; Patiag, D, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patiag, D | 1 |
| Gray, S | 1 |
| Idris, I | 1 |
| Donnelly, R | 1 |
1 other study available for ro 31-8220 and Insulin Resistance
| Article | Year |
|---|---|
Effects of tumour necrosis factor-alpha and inhibition of protein kinase C on glucose uptake in L6 myoblasts.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Humans; Indo | 2000 |